Aviance Capital Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.8M Sell
36,514
-466
-1% -$166K 1.5% 10
2025
Q4
$12.1M Buy
36,980
+3,566
+11% +$1.13M 1.4% 10
2025
Q3
$9.43M Buy
33,414
+547
+2% +$159K 1.12% 15
2025
Q2
$9.18M Buy
32,867
+228
+0.7% +$64.6K 1.2% 12
2025
Q1
$10.2M Buy
32,639
+587
+2% +$173K 1.43% 10
2024
Q4
$8.35M Buy
32,052
+218
+0.7% +$64.7K 1.15% 15
2024
Q3
$10.3M Buy
31,834
+45
+0.1% +$14.7K 1.35% 11
2024
Q2
$9.93M Buy
31,789
+293
+0.9% +$86.1K 1.41% 11
2024
Q1
$8.95M Buy
31,496
+7,910
+34% +$2.31M 1.33% 12
2023
Q4
$6.79M Sell
23,586
-526
-2% -$143K 1.45% 11
2023
Q3
$6.48M Buy
24,112
+118
+0.5% +$29.4K 1.46% 9
2023
Q2
$5.33M Buy
23,994
+1,441
+6% +$334K 1.13% 18
2023
Q1
$5.45M Sell
22,553
-131
-0.6% -$32.2K 1.21% 15
2022
Q4
$5.96M Sell
22,684
-102
-0.4% -$27.3K 1.39% 10
2022
Q3
$5.14M Sell
22,786
-805
-3% -$195K 1.27% 14
2022
Q2
$5.74M Buy
23,591
+293
+1% +$71.8K 1.28% 10
2022
Q1
$5.63M Buy
23,298
+12
+0.1% +$2.76K 1.03% 19
2021
Q4
$5.24M Buy
23,286
+400
+2% +$84.4K 0.87% 34
2021
Q3
$4.87M Buy
22,886
+1,162
+5% +$267K 0.86% 32
2021
Q2
$5.29M Buy
21,724
+598
+3% +$147K 0.93% 28
2021
Q1
$5.26M Sell
21,126
-594
-3% -$142K 1.01% 22
2020
Q4
$4.99M Buy
21,720
+96
+0.4% +$22.1K 1.01% 18
2020
Q3
$5.5M Buy
21,624
+426
+2% +$106K 1.24% 9
2020
Q2
$5M Buy
21,198
+949
+5% +$217K 1.23% 12
2020
Q1
$4.11M Sell
20,249
-197
-1% -$43K 1.29% 11
2019
Q4
$4.93M Sell
20,446
-889
-4% -$196K 1.26% 12
2019
Q3
$4.13M Buy
21,335
+334
+2% +$64.1K 1.21% 13
2019
Q2
$3.87M Buy
21,001
+500
+2% +$89.5K 1.07% 13
2019
Q1
$3.9M Sell
20,501
-5,993
-23% -$1.14M 1.12% 13
2018
Q4
$5.16M Sell
26,494
-3,678
-12% -$718K 1.81% 7
2018
Q3
$6.25M Buy
30,172
+1,422
+5% +$280K 1.51% 9
2018
Q2
$5.31M Buy
28,750
+502
+2% +$88.8K 1.53% 10
2018
Q1
$4.82M Sell
28,248
-3,361
-11% -$617K 1.45% 10
2017
Q4
$5.5M Buy
31,609
+568
+2% +$101K 1.81% 6
2017
Q3
$5.79M Sell
31,041
-8,163
-21% -$1.45M 1.96% 6
2017
Q2
$6.75M Buy
39,204
+919
+2% +$149K 2.17% 6
2017
Q1
$6.28M Sell
38,285
-441
-1% -$73.3K 2.29% 5
2016
Q4
$5.66M Buy
38,726
+1,161
+3% +$175K 2% 6
2016
Q3
$6.27M Buy
37,565
+1,032
+3% +$175K 2.21% 4
2016
Q2
$5.56M Buy
36,533
+3,307
+10% +$514K 2.05% 5
2016
Q1
$4.98M Buy
33,226
+5,538
+20% +$823K 1.73% 4
2015
Q4
$4.5M Sell
27,688
-163
-0.6% -$25.6K 1.54% 5
2015
Q3
$3.85M Sell
27,851
-850
-3% -$134K 1.58% 6
2015
Q2
$4.41M Buy
28,701
+110
+0.4% +$17.6K 1.65% 7
2015
Q1
$4.57M Buy
28,591
+277
+1% +$43.6K 1.67% 5
2014
Q4
$4.51M Buy
28,314
+304
+1% +$47.4K 1.68% 5
2014
Q3
$3.93M Sell
28,010
-1,125
-4% -$147K 1.49% 5
2014
Q2
$3.45M Buy
29,135
+305
+1% +$35.3K 1.35% 8
2014
Q1
$3.56M Sell
28,830
-730
-2% -$88.5K 1.5% 6
2013
Q4
$3.37M Buy
29,560
+875
+3% +$99.5K 1.42% 14
2013
Q3
$3.21M Sell
28,685
-1,701
-6% -$184K 1.5% 12
2013
Q2
$3M Buy
+30,386
New +$3.15M 1.62% 9

Other funds holding AMGN

Aviance Capital Partners's AMGN Position: Q1 2026 in Review

Aviance Capital Partners reduced its Amgen (AMGN) stake by 1.3% in Q1 2026, selling an estimated $166K and leaving 36,514 shares worth $12.8M. The position accounts for 1.5% of the portfolio, ranked #10.

Aviance Capital Partners first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Aviance Capital Partners held 36,514 shares of Amgen worth $12.8M as of Q1 2026.
  • Aviance Capital Partners sold 466 Amgen shares in Q1 2026, an estimated $166K.
  • Amgen made up 1.5% of Aviance Capital Partners's portfolio in Q1 2026, its #10 holding.
  • Aviance Capital Partners first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Aviance Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.